Published ahead of print on November 4, 2005, doi:10.1164/rccm.200506-917OC
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 288-296, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200506-917OC
Response to Acute Lung Infection with Mucoid Pseudomonas aeruginosa in Cystic Fibrosis Mice
Anna M. van Heeckeren,
Mark D. Schluchter,
Wei Xue and
Pamela B. Davis
Department of Pediatrics, Rainbow Babies and Children's Hospital, and Case Western Reserve University School of Medicine, Cleveland, Ohio
Correspondence and requests for reprints should be addressed to Anna M. van Heeckeren, D.V.M., M.S., Case Western Reserve University School of Medicine, Division of Pediatric Pulmonology, Biomedical Research Building 827, 2109 Adelbert Road, Cleveland, OH 44106-4948. E-mail: anna.vanheeckeren{at}case.edu
Rationale: Cystic fibrosis is caused by defects in the cystic fibrosis transmembrane conductance regulator gene, which codes for a chloride channel, but the role of this chloride channel in inflammation induced by lung infection with Pseudomonas aeruginosa remains to be defined.
Objectives: We tested the hypothesis that loss of this chloride channel alone is sufficient to cause excessive inflammation in response to inflammatory stimuli.
Methods: We investigated the response of cystic fibrosis and wild-type mice to mucoid P. aeruginosa administered by insufflation.
Measurements: The host responses measured included survival, weight change, lung morphometry, bacterial clearance, and inflammatory mediators, and cell counts were assessed in bronchoalveolar lavage fluid.
Main Results: Depending on the dose administered and frequency of dosing, cystic fibrosis mice experienced significantly higher mortality rates, greater weight loss, higher lung pathology scores, and higher inflammatory mediator and neutrophil levels compared with wild-type mice, even after the bacteria had been cleared. Surprisingly, bacteria were cleared just as rapidly in cystic fibrosis mice as in wild-type mice, and sepsis was not observed. Chronic lung infections could not be established with mucoid P. aeruginosa in either cystic fibrosis or wild-type mice.
Conclusions: Absence of this chloride channel alone appears sufficient for exaggerated inflammation and excess mortality compared with wild-type controls in the face of mucoid P. aeruginosa lung infection. To establish chronic infection, additional factors such as bacterial trapping or poor clearance may be required.
Key Words: cystic fibrosis cystic fibrosis transmembrane conductance regulator inflammation pathogenesis
This article has been cited by other articles:

|
 |

|
 |
 
H. Yu, Y. H. Zeidan, B. X. Wu, R. W. Jenkins, T. R. Flotte, Y. A. Hannun, and I. Virella-Lowell
Defective Acid Sphingomyelinase Pathway with Pseudomonas aeruginosa Infection in Cystic Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2009;
41(3):
367 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Bruscia, P.-X. Zhang, E. Ferreira, C. Caputo, J. W. Emerson, D. Tuck, D. S. Krause, and M. E. Egan
Macrophages Directly Contribute to the Exaggerated Inflammatory Response in Cystic Fibrosis Transmembrane Conductance Regulator-/- Mice
Am. J. Respir. Cell Mol. Biol.,
March 1, 2009;
40(3):
295 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Kukavica-Ibrulj and R C Levesque
Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies
Lab Anim,
October 1, 2008;
42(4):
389 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis
Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium
Am J Physiol Lung Cell Mol Physiol,
August 1, 2008;
295(2):
L303 - L313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Benarafa, G. P. Priebe, and E. Remold-O'Donnell
The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection
J. Exp. Med.,
August 6, 2007;
204(8):
1901 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Saadane, S. Masters, J. DiDonato, J. Li, and M. Berger
Parthenolide Inhibits I{kappa}B Kinase, NF-{kappa}B Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice
Am. J. Respir. Cell Mol. Biol.,
June 1, 2007;
36(6):
728 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Dechecchi, E. Nicolis, V. Bezzerri, A. Vella, M. Colombatti, B. M. Assael, Y. Mettey, M. Borgatti, I. Mancini, R. Gambari, et al.
MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells
Am. J. Respir. Cell Mol. Biol.,
May 1, 2007;
36(5):
615 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Accurso
Update in Cystic Fibrosis 2006
Am. J. Respir. Crit. Care Med.,
April 15, 2007;
175(8):
754 - 757.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Reiniger, M. M. Lee, F. T. Coleman, C. Ray, D. E. Golan, and G. B. Pier
Resistance to Pseudomonas aeruginosa Chronic Lung Infection Requires Cystic Fibrosis Transmembrane Conductance Regulator-Modulated Interleukin-1 (IL-1) Release and Signaling through the IL-1 Receptor
Infect. Immun.,
April 1, 2007;
75(4):
1598 - 1608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Dubin and J. K. Kolls
IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L519 - L528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch
Cystic Fibrosis Mouse Models
Am. J. Respir. Cell Mol. Biol.,
January 1, 2007;
36(1):
1 - 7.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|